Use of drugeluting stents in this patient group varies from 2. What is restenosis, know its types, causes, symptoms, treatment. Oct 31, 2017 restenosis refers to the recurrence of the problem of stenosis or narrowing of blood vessels, which result in restrictions in the flow of blood in the human body. Dangas, md, phd even in the contemporary era of percutaneous coronary intervention using drugeluting stents, in stent restenosis isr remains a common problem, occurring in 5% to 20% of cases, depending on several. Bare metal stent restenosis is not a benign clinical entity. Tips and tricks for management of instent restenosis scai. Cases are treated with with various options, including drugs, mechanical. Many interventional cardiologists commonly use the stent in stent technique sandwich technique to treat des isr, despite the lack of supporting clinical evidence. The stent length was selected to equal or exceed the length of the angioplasty balloon. Nanoparticle drug and geneeluting stents for the prevention. A new form of restenosis, namely in stent restenosis isr following bms implantation, is responsible for a large proportion of repeat pci procedures.
Isr progresses through several different phases and involves numerous cellular and molecular constituents. Clinical presentation and outcomes of coronary instent restenosis. In the pre stent era the occurrence of restenosis ranged between 3255% of all angioplasties, and drop to successively 1741% in the bare metal stents bms era. Jun 18, 2014 computed tomography coronary angiography is a valuable imaging modality for assessing coronary artery disease, but its diagnostic value in the assessment of in stent restenosis is limited in heavily calcified arteries, intermediate or small arteries or stents, thick stent struts, and regions of stent overlap.
Outcomes after sirolimuseluting stent implantation for diffuse instent restenosis. Restenosis was originally the major limitation in using angioplasty and stents for coronary artery disease. Percutaneous coronary intervention pci has become the most common revascularization procedure for coronary artery disease. Restenosis of the coronary arteries pdf free download. Aug 23, 2018 there are many reasons for ongoing inflammation in the coronary artery, and prolonged healing, after angioplasty, with or without stent insertion. Sharma, md stent implantation has become the mainstay of percutaneous revascularization for most. Currently, there is a trend toward use of drugcoated balloon angioplasty instead of stents, and this is expected to lead to a significant reduction in the number of stents that will be implanted in the superficial femoral artery. The biology of instent restenosis and the rationale for. Isr mainly results from aggressive neointimal proliferation, but recent data also suggest that neoatherosclerosis may play an important pathophysiological role. Autopsy studies and intravascular imaging have augmented our understanding of the pathophysiology of isr. The introduction of bare metal stents bms over 30 years ago was a significant milestone in the evolution of percutaneous coronary. J goy on behalf of the members of the working group on coronary circulation of the european society of cardiology aims in europe, no written oycial guidelines on indications for coronary stent placement are available. Prevention of instent restenosis with endothelial progenitor. There are many reasons for ongoing inflammation in the coronary artery, and prolonged healing, after angioplasty, with or without stent insertion.
Revelutionizing drugeluting technologies boston scientific. Drugeluting stents des have dramatically reduced the rates of restenosis and target lesion revascularization tlr compared with baremetal stents bms 2. Although the use of stents in coronary intervention procedures are adopted worldwide, several patients exhibits instent restenosis isr due to the thick accumulation of vascular tissue after stent being placed 4,6,10,11, lead. In addition, the stent length was selected both to completely cover the entire diseased segment and to allow positioning of the proximal end of the stent so as not to preclude future endovascular access into the stented segment. Comparing treatment options for restenosis shows that a drugeluting stent is a safe and effective procedure. Jun 24, 2014 management of patients with in stent restenosis isr remains an important clinical problem. As percutaneous coronary intervention increasingly involves the use of stents. The long term outcome of stent implantation is affected by a process called in stent restenosis isr. Even with drugeluting stents, the risk of in stent restenosis isr remains high.
Apr 12, 2012 treating restenosis in patients with stents restenosis is the renarrowing of the arteries after angioplasty. Tips and tricks for management of instent restenosis. Learn about its various causes, prevention, and the treatments. Classification and implications for longterm outcome. Jul 04, 2017 a simple restenosis definition is the reoccurrence of stenosis. However, in stent restenosis remains one of the major drawbacks of this procedure. All content in this area was uploaded by keith g oldroyd on jun 02, 2015.
This problem mainly takes place due to either narrow artery or any other large vessel of the blood. Sep 08, 2016 the exact incidence of instent restenosis isr is not easy to determine caused by different clinical, angiographic and operative factors. Mca in stent restenosis with correlative cta and dsa. Hypersensitivity reaction is a classic cause of instent restenosis isr in coronary stents. Coronary instent restenosis journal of invasive cardiology. The goal of this study was to investigate the use of an endothelial progenitor cell epc capture stent plus regional epc transplantation to reduce the isr rate. It wont cause symptoms until the blockage is bad enough to keep the heart from getting the minimum amount of blood it needs. Know the types, causes, symptoms and treatment for restenosis. Instent restenosis isr, defined as 50 percent diameter stenosis, accounts for about 10 percent of all percutaneous coronary interventions. In the era of baremetal stents bms, restenosis rates were. Instent restenosis in the drugeluting stent era whba. The exact incidence of in stent restenosis isr is not easy to determine caused by different clinical, angiographic and operative factors. Even in the contemporary era of percutaneous coronary intervention using drugeluting stents, instent restenosis isr remains a common problem, occurring in. In this 35th year of percutaneous coronary intervention, restenosis after stent implantation remains a significant limitation, resulting in increased costs and morbidity, reduced quality of life, and in some patients, a need for surgical coronary revascularization.
Although intracoronary stent restenosis isr is much less common with the use of drugeluting stents des than with bare metal stents bms, the number of stents being implanted in interventional practice means that the treatment of isr remains an important clinical challenge. Jan 02, 2017 rewards instent restenosis the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. In the prestent era the occurrence of restenosis ranged between 3255% of all angioplasties, and drop to successively 1741% in the bare metal stents bms era. Pdf coronary stent implantation has significantly improved percutaneous coronary intervention and enabled the management of early. This study, conducted at a tertiary referral heart center in tehran, recruited 100 patients. Instent restenosis isr is a critical drawback of coronary stents and remains the leading cause of unplanned, repeat procedures in the drugeluting stent des. The clinical presentation and symptoms vary considerably among patients from stable angina to unstable angina and acute myocardial infarction.
Restenosis is defined as a reduction in lumen diameter after percutaneous coronary intervention pci, either with or without stent implantation. The isardesire intracoronary stenting or angioplasty for restenosis reductiondrugeluting stents for in stent restenosis trial was the first randomized study assessing the value of des in patients with bmsisr. Listing a study does not mean it has been evaluated by the u. In this 2center german trial, 300 patients were randomly allocated to treatment with sirolimusdes, paclitaxeldes, or ba. In some patients, restenosis may be caused by technical factors as stent misplacement, a gap between two stents or a. Jan 19, 2016 management of in stent restenosis isr remains a clinical challenge after both bare metal stent and drugeluting stent placement. As stent technology has improved, restenosis has now been greatly limited as a problem.
Even when a stent is implanted, restenosis can develop inside the stent. Cta appearance of instent restenosis of intracranial. It occurs in as many as 40 to 50 percent of people who. Restenosis, a narrowing of a blood vessels, following angioplasty or stent placement is seen in up to 50% of patients. Note the extensive blooming effect related to coronary stent in comparison to the adjacent wingspan stent.
Incidence, predictors, treatment, and longterm prognosis of. Mdcta, if there was evidence of in stent restenosis by mdcta the patient was subjected for conventional coronary angiography. Angiographic patterns of instent restenosis aha journals. Stent restenosis after drug eluting stent desisr for diffuse des isr are important ongoing trials. The use of stents has reduced the rate of restenosis by preventing elastic recoil and negative remodeling. Restenosis, with or without a stent, occurs gradually. Learn more about treatment options from the number one heart center, cleveland clinic. Although drugeluting stents des have drastically reduced the incidence of isr, treatment of desisr is particularly challenging. Repetitive restenosis in a biodegradable polymer sirolimus.
A comparison of clinical presentations, angiographic patterns and outcomes of instent restenosis between bare metal stents and drug eluting stents. The eluvia stent incorporates paclitaxel in a biocompatible fluoropolymer coating to provide sustained and controlled drug release. It allows the blood to flow freely through the stent without clotting. Thesedevicesballoon angioplasty, atherectomy directional, rotational, and laser, and repeat stenting stentinstent provided a high rate of immediate technical success and a low rate of ischemic events, but 30% to 60% of patients re. Its main late complication is the development of instent restenosis isr, occurring in 1080% of lesions treated in daily practice. Even in the contemporary era of percutaneous coronary intervention using drug eluting stents, instent restenosis isr remains a common problem, occurring in. We describe the fracture of a double layer of stents caused by nodular calcification.
Mehran r, dangas g, abizaid as, mintz gs, lansky aj, satler lf, pichard ad, kent km, stone gw, and leon mb. Pdf classification and current treatment options of instent. Restenosis means that a section of blocked artery that was opened up with angioplasty or a stent has become narrowed again. It cannot be detected by angiography and generally it occurs in vessels with tortuosity or different diameters within the treated segment. Histopathologic substrate of in stent restenosis is neointimal hyperplasia. Marmur, md, george dangas, md, phd, sanjay choudhary, md, and samin k. We classified a total of 288 isr lesions in 245 patients and verified the angiographic accuracy of the classification by intravascular ultrasound. It was of great interest and utility to read the paper by dangas et al. Treatment of patients with instent restenosis isr remains a challenge 1. Comparison with brachytherapy amc rt vs ses comparison of the 6month and 2year outcomes of sirolimuseluting stent implantation versus.
Isr which is currently defined as a 50% stenosis of a previously stented segment, occurs in as many as 30% of all patients receiving bare metal. Restenosis is the recurrence of stenosis, a narrowing of a blood vessel, leading to restricted blood flow. Angiographic patterns of instent restenosis and implications. Approximately 5% of patients referred for coronary stenting are on longterm oral anticoagulation. The use of drugeluting stents des has lowered the incidence of isr further, with clinical restenosis rates less than 10% in contemporary practice. Restenosis usually pertains to an artery or other large blood vessel that has become narrowed, received treatment to clear the blockage and subsequently become renarrowed. Aug 23, 2018 restenosis, a narrowing of a blood vessels, following angioplasty or stent placement is seen in up to 50% of patients. Multiple contributory factors have been identified, but clear understanding of the overall underlying mechanism remains an enigma. Stent restenosis, pathophysiology and treatment options. While repeat des implantation seems preferable, the optimal stent type is not.
593 1124 1247 403 1593 393 145 517 1491 308 957 143 1034 124 1192 153 812 254 1227 1553 780 593 1262 301 270 786 868 323 444 351 687 680 1374 946 1296 714 60 1341 193 678 951 228